BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

574 hedge funds and large institutions have $10.1B invested in BioMarin Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 239 increasing their positions, 184 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
574
Holders Change
-4
Holders Change %
-0.69%
% of All Funds
7.7%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
85
Increased
239
Reduced
184
Closed
81
Calls
$81.1M
Puts
$73M
Net Calls
+$8.09M
Net Calls Change
-$1.92M

Top Buyers

1
AQR Capital Management
AQR Capital Management
Connecticut
+$146M
2
Millennium Management
Millennium Management
New York
+$119M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$81.8M
4
Morgan Stanley
Morgan Stanley
New York
+$76.2M
5
Renaissance Technologies
Renaissance Technologies
New York
+$50.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$481M
2
EIM
Elliott Investment Management
Florida
-$247M
3
Ameriprise
Ameriprise
Minnesota
-$112M
4
Primecap Management
Primecap Management
California
-$110M
5
NL
Nuveen LLC
North Carolina
-$103M
Name Holding Trade Value Shares
Change 		Shares
Change %
WW
651
Winnow Wealth
Texas
– -$396 -6 Closed
BI
652
Binnacle Investments
Iowa
– -$424 -6 Closed
WCM
653
WealthTrak Capital Management
Virginia
– -$354 -5 Closed
BF
654
BOK Financial
Oklahoma
– -$283 -4 Closed
BCM
655
Blume Capital Management
California
– -$142 -2 Closed
23 24 25 26
27